GI
PRCT icon

GAMMA Investing’s Procept Biorobotics PRCT Stock Holding History

GAMMA Investing’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.64K Sell
145
-149
-51% -$2.97K ﹤0.01% 3872
2026
Q2 		$6.64K Sell
294
-40
-12% -$1K ﹤0.01% 3367
2026
Q1 		$8.35K Buy
334
+99
+42% +$2.79K ﹤0.01% 3164
2025
Q4 		$7.39K Buy
235
+132
+128% +$4.38K ﹤0.01% 3114
2025
Q3 		$3.68K Sell
103
-64
-38% -$2.92K ﹤0.01% 3289
2025
Q2 		$9.62K Buy
167
+57
+52% +$3.22K ﹤0.01% 2821
2025
Q1 		$6.41K Buy
110
+20
+22% +$1.37K ﹤0.01% 2969
2024
Q4 		$7.25K Buy
90
+50
+125% +$4.27K ﹤0.01% 2755
2024
Q3 		$3.21K Buy
40
+22
+122% +$1.56K ﹤0.01% 2913
2024
Q2 		$1.1K Buy
18
+12
+200% +$714 ﹤0.01% 3030
2024
Q1 		$297 Hold
6
– – ﹤0.01% 3181
2023
Q4 		$278 Buy
+6
New +$204 ﹤0.01% 3089

Other funds holding PRCT

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

GAMMA Investing's PRCT Position: Q3 2026 in Review

GAMMA Investing reduced its Procept Biorobotics (PRCT) stake by 51% in Q3 2026, selling an estimated $2.97K and leaving 145 shares worth $2.64K. The position accounts for ﹤0.01% of the portfolio, ranked #3872.

GAMMA Investing first reported a position in PRCT in Q4 2023 and has held it in 12 quarters since. The position peaked at $9.62K in Q2 2025. 7 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • GAMMA Investing held 145 shares of Procept Biorobotics worth $2.64K as of Q3 2026.
  • GAMMA Investing sold 149 Procept Biorobotics shares in Q3 2026, an estimated $2.97K.
  • Procept Biorobotics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3872 holding.
  • GAMMA Investing first reported a position in Procept Biorobotics in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Procept Biorobotics position peaked at $9.62K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.